Published in Mov Disord on January 01, 2005
Proteome analysis of human substantia nigra in Parkinson's disease. Proteome Sci (2008) 1.06
Parkinson disease and comorbid cerebrovascular disease. Nat Rev Neurol (2009) 0.97
Cobalamin deficiency, hyperhomocysteinemia, and dementia. Neuropsychiatr Dis Treat (2010) 0.94
The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular parkinsonism. PLoS One (2011) 0.91
Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype. Psychopharmacology (Berl) (2014) 0.84
Tolcapone decreases plasma levels of S-adenosyl-L-homocysteine and homocysteine in treated Parkinson's disease patients. Eur J Clin Pharmacol (2006) 0.82
Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference. Patient Prefer Adherence (2009) 0.81
Possible treatment concepts for the levodopa-related hyperhomocysteinemia. Cardiovasc Psychiatry Neurol (2009) 0.78
Peripheral COMT inhibition prevents levodopa associated homocysteine increase. J Neural Transm (Vienna) (2009) 0.77
Inhibition of catechol-O-methyltransferase modifies acute homocysteine rise during repeated levodopa application in patients with Parkinson's disease. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.77
Autonomic nervous system and risk factors for vascular disease. Effects of autonomic unbalance in schizophrenia and Parkinson's disease. Neurol Sci (2008) 0.77
Comparison of endothelial progenitor cells in Parkinson's disease patients treated with levodopa and levodopa/COMT inhibitor. PLoS One (2011) 0.75
Homocysteine Levels in Parkinson's Disease: Is Entacapone Effective? Biomed Res Int (2016) 0.75
COMT Val158Met polymorphism is associated with blood pressure and lipid levels in general families of Bama longevous area in China. Int J Clin Exp Pathol (2015) 0.75
A Comparative Study of Central Hemodynamics in Parkinson's Disease. J Mov Disord (2017) 0.75
New natural history of interferon-beta-treated relapsing multiple sclerosis. Ann Neurol (2007) 3.87
A comparative study of cortical responses evoked by transcutaneous electrical vs CO(2) laser stimulation. Clin Neurophysiol (2011) 2.83
Epidemiology of primary dystonia. Lancet Neurol (2004) 1.71
Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. J Neurol Sci (2007) 1.61
Hirayama disease: the importance of an early diagnosis. Neurol Sci (2015) 1.55
Serum levels of N-acetyl-aspartate in migraine and tension-type headache. J Headache Pain (2012) 1.54
Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity. Invest Ophthalmol Vis Sci (2005) 1.20
Age-related disability in multiple sclerosis. Ann Neurol (2002) 1.12
Rate of MMSE score change in Alzheimer's disease: influence of education and vascular risk factors. Clin Neurol Neurosurg (2008) 1.07
The phenomenology of the geste antagoniste in primary blepharospasm and cervical dystonia. Mov Disord (2010) 1.05
Disassembly of shank and homer synaptic clusters is driven by soluble beta-amyloid(1-40) through divergent NMDAR-dependent signalling pathways. PLoS One (2009) 1.05
Validity of family history data on primary adult-onset dystonia. Arch Neurol (2004) 1.05
Predictors of long survival in amyotrophic lateral sclerosis: a population-based study. J Neurol Sci (2007) 1.05
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes. J Neuroimmunol (2003) 1.04
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. PLoS One (2012) 1.04
Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study. J Neurol Sci (2006) 1.01
Influence of Interferon beta treatment on quality of life in multiple sclerosis patients. Health Qual Life Outcomes (2006) 1.01
Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol (2002) 1.01
Relationship between eye symptoms and blepharospasm: a multicenter case-control study. Mov Disord (2005) 1.00
Tremor in primary adult-onset dystonia: prevalence and associated clinical features. J Neurol Neurosurg Psychiatry (2012) 0.99
The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler (2010) 0.99
The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNbeta exposure in multiple sclerosis. Mult Scler (2006) 0.97
Lack of habituation of nociceptive evoked responses and pain sensitivity during migraine attack. Clin Neurophysiol (2005) 0.96
Neurofilament ELISA validation. J Immunol Methods (2009) 0.96
Novel Italian family supports clinical and genetic heterogeneity of primary adult-onset torsion dystonia. Mov Disord (2002) 0.96
Physical activity and amyotrophic lateral sclerosis: a European population-based case-control study. Ann Neurol (2014) 0.94
Clinical features of headache patients with fibromyalgia comorbidity. J Headache Pain (2011) 0.94
Epidemiology of primary blepharospasm. Mov Disord (2002) 0.93
Cortical gray matter changes in primary blepharospasm: a voxel-based morphometry study. Mov Disord (2011) 0.93
Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy. Mult Scler (2003) 0.92
Glatiramer acetate in multiple sclerosis: a review. CNS Drug Rev (2007) 0.92
Multigate quality Doppler profiles and morphological/hemodynamic alterations in multiple sclerosis patients. Curr Neurovasc Res (2012) 0.91
Primary blepharospasm: diagnosis and management. Drugs (2004) 0.90
Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid. Alzheimers Dement (2011) 0.90
Habituation of single CO2 laser-evoked responses during interictal phase of migraine. J Headache Pain (2005) 0.89
ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy. J Neurol (2007) 0.88
Brain F-18 Fluorocholine PET/CT for the assessment of optic pathway glioma in neurofibromatosis-1. Clin Nucl Med (2010) 0.88
Pain in prolonged disorders of consciousness: laser evoked potentials findings in patients with vegetative and minimally conscious states. Brain Inj (2013) 0.88
Laser-evoked potentials habituation in fibromyalgia. J Pain (2010) 0.88
The TOR1A polymorphism rs1182 and the risk of spread in primary blepharospasm. Mov Disord (2009) 0.88
Planning genetic studies on primary adult-onset dystonia: sample size estimates based on examination of first-degree relatives. J Neurol Sci (2006) 0.87
Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta. J Interferon Cytokine Res (2005) 0.86
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia. Mov Disord (2009) 0.86
Aesthetic value of paintings affects pain thresholds. Conscious Cogn (2008) 0.86
Acute extrapyramidal disorder with bilateral reversible basal ganglia lesions in a diabetic uremic patient: diffusion-weighted imaging and spectroscopy findings. J Neurol Sci (2010) 0.86
Familial blepharospasm is inherited as an autosomal dominant trait and relates to a novel unassigned gene. Mov Disord (2003) 0.86
Voltage-gated sodium channel blockers as immunomodulators. Recent Pat CNS Drug Discov (2006) 0.86
Virtual visual effect of hospital waiting room on pain modulation in healthy subjects and patients with chronic migraine. Pain Res Treat (2013) 0.85
Midbrain SERT in degenerative parkinsonisms: a 123I-FP-CIT SPECT study. Mov Disord (2010) 0.85
Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patients. J Neuroimmunol (2004) 0.85
Hyperhomocysteinemia in movement disorders: Current evidence and hypotheses. Curr Vasc Pharmacol (2006) 0.85
Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features. J Neurol (2013) 0.85
Two years' follow-up of rivastigmine treatment in Huntington disease. Clin Neuropharmacol (2007) 0.85
Molecular analysis in a family presenting with a mild form of late-onset autosomal dominant chronic progressive external ophthalmoplegia. Neuromuscul Disord (2009) 0.85
Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study. Mov Disord (2009) 0.84
Influence of MTHFR genotype on contingent negative variation and MRI abnormalities in migraine. Headache (2007) 0.84
Effects of affective pictures on pain sensitivity and cortical responses induced by laser stimuli in healthy subjects and migraine patients. Int J Psychophysiol (2009) 0.84
CDK5 is essential for soluble amyloid β-induced degradation of GKAP and remodeling of the synaptic actin cytoskeleton. PLoS One (2011) 0.84
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease. J Neurol (2010) 0.83
Reversible Parkinsonian syndrome associated with anti-neuronal antibodies in acute EBV encephalitis: a case report. Parkinsonism Relat Disord (2006) 0.83
Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. Neurosci Lett (2008) 0.82
Primary angiitis of the central nervous system: a misinterpreted clinical onset of CNS vasculitis. Eur Neurol (2005) 0.82
Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis. PLoS One (2013) 0.82
Low serum urate levels are associated to female gender in multiple sclerosis patients. PLoS One (2012) 0.82
Differential regulation of membrane bound and soluble ICAM 1 in human endothelium and blood mononuclear cells: effects of interferon beta-1a. Cell Commun Adhes (2003) 0.82
Sleep features and central sensitization symptoms in primary headache patients. J Headache Pain (2014) 0.82
β-Site amyloid precursor protein-cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin-related receptor with A-type repeats, soluble amyloid precursor protein, and tau. Alzheimers Dement (2012) 0.82
Serum levels of N-acetylaspartate in Huntington's disease: preliminary results. Mov Disord (2011) 0.81
Motoneuron disease after electric injury: a case report. Neurol Sci (2008) 0.81
Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy. Neuroimmunomodulation (2012) 0.81
Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients. Parkinsonism Relat Disord (2013) 0.81
Influence of aesthetic perception on visual event-related potentials. Conscious Cogn (2007) 0.81
Intra-oral orthosis vs amitriptyline in chronic tension-type headache: a clinical and laser evoked potentials study. Head Face Med (2006) 0.81
Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis. J Neurol Sci (2005) 0.81
Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesias. Clin Chem Lab Med (2006) 0.81
Pain perception and laser evoked potentials during menstrual cycle in migraine. J Headache Pain (2009) 0.81
Topographic analysis of laser evoked potentials in chronic tension-type headache: correlations with clinical features. Int J Psychophysiol (2006) 0.80
A new locus on 3p23-p25 for an autosomal-dominant limb-girdle muscular dystrophy, LGMD1H. Eur J Hum Genet (2010) 0.80
Efficacy of levetiracetam in Huntington disease. Clin Neuropharmacol (2005) 0.80
Serum N-acetylaspartate level in amyotrophic lateral sclerosis. Arch Neurol (2011) 0.80
Laser evoked potentials in carpal tunnel syndrome. Clin Neurophysiol (2009) 0.80
Changes in cortical processing of pain in chronic migraine. Headache (2005) 0.80
Tertiary treatment for psychiatric comorbidity in headache patients. J Headache Pain (2005) 0.80
Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions. Clin Chem Lab Med (2005) 0.80
Effects of high-frequency repetitive transcranial magnetic stimulation of primary motor cortex on laser-evoked potentials in migraine. J Headache Pain (2010) 0.80
Further evidence that D90A-SOD1 mutation is recessively inherited in ALS patients in Italy. Amyotroph Lateral Scler (2009) 0.79
Effects of remote cutaneous pain on trigeminal laser-evoked potentials in migraine patients. J Headache Pain (2007) 0.79
Mitochondrial genome aberrations in skeletal muscle of patients with motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener (2012) 0.79